Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37.5K Sell
370
-7,824
-95% -$895K ﹤0.01% 1704
2026
Q2
$969K Buy
8,194
+8,059
+5,970% +$930K 0.04% 408
2026
Q1
$16.3K Buy
135
+7
+5% +$918 ﹤0.01% 1806
2025
Q4
$17.4K Buy
128
+3
+2% +$431 ﹤0.01% 1810
2025
Q3
$18.5K Buy
125
+18
+17% +$2.5K ﹤0.01% 1613
2025
Q2
$13.9K Hold
107
– – ﹤0.01% 1652
2025
Q1
$12.8K Buy
107
+9
+9% +$1.12K ﹤0.01% 1657
2024
Q4
$11.3K Buy
98
+61
+165% +$7.71K ﹤0.01% 1713
2024
Q3
$4.93K Buy
+37
New +$4.95K ﹤0.01% 2013

Other funds holding XYL

BFC Planning's XYL Position: Q3 2026 in Review

BFC Planning reduced its Xylem (XYL) stake by 95% in Q3 2026, selling an estimated $895K and leaving 370 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1704.

BFC Planning first reported a position in XYL in Q3 2024 and has held it in 9 quarters since. The position peaked at $969K in Q2 2026. 938 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • BFC Planning held 370 shares of Xylem worth $37.5K as of Q3 2026.
  • BFC Planning sold 7,824 Xylem shares in Q3 2026, an estimated $895K.
  • Xylem made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1704 holding.
  • BFC Planning first reported a position in Xylem in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Xylem position peaked at $969K in Q2 2026.
  • 938 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.